TTR and amyloidosis: Recent data demonstrated the capability of TG68 to stimulate oligodendrocytes (OPC) differentiation and overcome inflammation-mediated pathological conditions [31], as well as to potently inhibit transthyretin (TTR)-mediated amyloidosis (TTRA) [32], suggesting a potential role in counteracting neuroinflammation and mitigating neuropsychological symptoms.